Inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC), are multifactorial disorders that result from a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. Recently, microRNAs (miRNAs) have been shown to be involved in the development of IBDs.
Ciccacci, C., Politi, C., Biancone, L., Latini, A., Novelli, G., Calabrese, E., et al. (2017). Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases. MOLECULAR DIAGNOSIS & THERAPY, 21(1), 107-114 [10.1007/s40291-016-0240-1].
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases
CICCACCI, CINZIA;BIANCONE, LIVIA;NOVELLI, GIUSEPPE;CALABRESE, EMMA;BORGIANI, PAOLA
2017-01-01
Abstract
Inflammatory bowel diseases (IBDs), including Crohn's disease (CD) and ulcerative colitis (UC), are multifactorial disorders that result from a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. Recently, microRNAs (miRNAs) have been shown to be involved in the development of IBDs.File | Dimensione | Formato | |
---|---|---|---|
Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
688.4 kB
Formato
Adobe PDF
|
688.4 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.